Total Payments
$6,915
2024 Payments
$740.00
Companies
28
Transactions
320
Medicare Patients
1,163
Medicare Billing
$77,852
Payment Breakdown by Category
Food & Beverage$6,898 (99.8%)
Education$17.10 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,898 | 318 | 99.8% |
| Education | $17.10 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,249 | 75 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $710.52 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $705.30 | 36 | $0 (2024) |
| Lilly USA, LLC | $476.26 | 13 | $0 (2023) |
| PFIZER INC. | $446.74 | 26 | $0 (2024) |
| GENZYME CORPORATION | $439.14 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $396.67 | 19 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $355.68 | 7 | $0 (2023) |
| Janssen Biotech, Inc. | $317.86 | 16 | $0 (2022) |
| Allergan Inc. | $292.75 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $740.00 | 37 | E.R. Squibb & Sons, L.L.C. ($168.61) |
| 2023 | $1,000 | 40 | E.R. Squibb & Sons, L.L.C. ($211.48) |
| 2022 | $636.84 | 32 | ABBVIE INC. ($177.72) |
| 2021 | $679.81 | 40 | AbbVie Inc. ($215.37) |
| 2020 | $553.81 | 26 | Sun Pharmaceutical Industries Inc. ($154.89) |
| 2019 | $1,185 | 48 | AbbVie, Inc. ($206.58) |
| 2018 | $964.49 | 49 | Novartis Pharmaceuticals Corporation ($233.50) |
| 2017 | $1,155 | 48 | Allergan Inc. ($292.75) |
All Payment Transactions
320 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.62 | General |
| Category: Immunology | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.58 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.99 | General |
| Category: Immunology | ||||||
| 08/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $37.05 | General |
| Category: Immunology | ||||||
| 08/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Dermatology | ||||||
| 08/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.14 | General |
| Category: Immunology | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Dermatology | ||||||
| 07/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: IMMUNOLOGY | ||||||
| 07/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.60 | General |
| Category: Immunology | ||||||
| 06/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.50 | General |
| Category: Immunology | ||||||
| 06/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: DERMATOLOGY | ||||||
| 06/14/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Dermatology | ||||||
| 06/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.22 | General |
| Category: Immunology | ||||||
| 06/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Immunology | ||||||
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.44 | General |
| Category: Immunology | ||||||
| 05/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Dermatology | ||||||
| 04/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Dermatology | ||||||
| 04/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.48 | General |
| Category: Immunology | ||||||
| 04/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Dermatology | ||||||
| 04/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: IMMUNOLOGY | ||||||
| 03/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.67 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 307 | 522 | $41,542 | $20,881 |
| 2022 | 7 | 308 | 570 | $39,772 | $21,062 |
| 2021 | 7 | 297 | 583 | $37,815 | $21,175 |
| 2020 | 7 | 251 | 377 | $29,290 | $14,734 |
Total Patients
1,163
Total Services
2,052
Medicare Billing
$77,852
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 105 | 132 | $13,200 | $7,181 | 54.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 46 | $6,946 | $3,951 | 56.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 32 | 41 | $5,111 | $2,714 | 53.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 26 | 31 | $4,526 | $2,497 | 55.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 43 | 63 | $6,750 | $2,193 | 32.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 29 | $1,769 | $1,195 | 67.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 32 | 165 | $2,145 | $692.59 | 32.3% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 12 | 15 | $1,095 | $457.51 | 41.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 106 | 142 | $14,200 | $8,314 | 58.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 35 | 44 | $6,178 | $3,665 | 59.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 40 | $5,622 | $3,302 | 58.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 38 | 43 | $5,375 | $2,239 | 41.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 43 | 50 | $4,783 | $1,766 | 36.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 36 | 233 | $2,363 | $1,208 | 51.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 18 | $1,251 | $567.48 | 45.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 97 | 125 | $12,500 | $7,869 | 62.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 43 | $6,020 | $3,625 | 60.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 36 | 38 | $5,320 | $2,961 | 55.7% |
| 17000 | Destruction of skin growth | Office | 2021 | 45 | 60 | $5,680 | $2,337 | 41.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 27 | 31 | $3,875 | $2,205 | 56.9% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 34 | 260 | $2,600 | $1,298 | 49.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 23 | 26 | $1,820 | $881.00 | 48.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 98 | 106 | $10,600 | $5,391 | 50.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 26 | 33 | $4,620 | $2,813 | 60.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 30 | 31 | $3,875 | $2,038 | 52.6% |
About Dr. Cornelie Jones, MD
Dr. Cornelie Jones, MD is a Dermatology healthcare provider based in Orchard Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699772913.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cornelie Jones, MD has received a total of $6,915 in payments from pharmaceutical and medical device companies, with $740.00 received in 2024. These payments were reported across 320 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($6,898).
As a Medicare-enrolled provider, Jones has provided services to 1,163 Medicare beneficiaries, totaling 2,052 services with total Medicare billing of $77,852. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Orchard Park, NY
- Active Since 07/01/2005
- Last Updated 09/25/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1699772913
Products in Payments
- ILUMYA (Biological) $569.27
- COSENTYX (Biological) $543.85
- EUCRISA (Drug) $433.18
- SKYRIZI (Biological) $405.00
- Sotyktu (Drug) $377.38
- TALTZ (Drug) $371.78
- DUPIXENT (Biological) $346.16
- REMICADE (Biological) $317.86
- Humira (Biological) $311.57
- RINVOQ (Biological) $298.57
- DUPIXENT (Drug) $296.52
- ACZONE (Drug) $258.27
- Otezla (Drug) $222.20
- HUMIRA (Biological) $183.98
- COSENTYX (Drug) $161.45
- DUPIXENT DUPILUMAB INJECTION (Biological) $152.14
- OPZELURA (Drug) $132.79
- Finacea (Drug) $130.74
- Bimzelx (Biological) $122.92
- Cimzia (Drug) $121.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.